Literature DB >> 1497462

Within-subject biological variation of hematological quantities and analytical goals.

D Dot1, J Miró, X Fuentes-Arderiu.   

Abstract

For several common hematological quantities, the within-subject biological variation during a 1-year period was estimated in a group of 39 apparently healthy volunteers: 19 women and 20 men. All measurements were performed with a hematological analyzer (Toa E-5000, Toa Medical Electronics, Kobe, Japan). The means of the within-subject biological coefficients of variation, separated by sex when significant difference was shown, were as follows: 2.8% for hemoglobin concentration; 3.0% for erythrocyte concentration; 2.9% for erythrocyte volume fraction; 1.1% for mean erythrocyte volume; 1.9% for arbitrary SD of erythrocyte volume; 1.6% for mean erythrocyte hemoglobin concentration; 1.3% for mean erythrocyte hemoglobin; 10.8% in men and 15.7% in women for leukocyte concentration; and 6.7% in men and 8.6% in women for platelet concentration. The desirable between-day imprecisions for the measurement of each quantity were established as one half of the average of within-subject biological variation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1497462

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  7 in total

Review 1.  Haematocrit: within-subject and seasonal variation.

Authors:  Poul Thirup
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

2.  Reference change values of blood analytes from physically active subjects.

Authors:  Lázaro Alessandro S Nunes; René Brenzikofer; Denise Vaz de Macedo
Journal:  Eur J Appl Physiol       Date:  2010-05-06       Impact factor: 3.078

3.  Oral iron supplementation after blood donation: a randomized clinical trial.

Authors:  Joseph E Kiss; Donald Brambilla; Simone A Glynn; Alan E Mast; Bryan R Spencer; Mars Stone; Steven H Kleinman; Ritchard G Cable
Journal:  JAMA       Date:  2015-02-10       Impact factor: 56.272

4.  Hemoglobin variability in nondialysis chronic kidney disease: examining the association with mortality.

Authors:  Neil C Boudville; Ognjenka Djurdjev; Iain C Macdougall; Angel L M de Francisco; Gilbert Deray; Anatole Besarab; Paul E Stevens; Rowan G Walker; Pablo Ureña; Pablo Iñigo; Roberto Minutolo; Yosef S Haviv; Karen Yeates; Marisa L Agüera; Jennifer M MacRae; Adeera Levin
Journal:  Clin J Am Soc Nephrol       Date:  2009-05-07       Impact factor: 8.237

5.  Randomized double-blind clinical trial of a new human epoetin versus a commercially available formula for anemia control in patients on hemodialysis.

Authors:  Paulo D Picon; Suzane Cristina M Pribbernow; Carlos A Prompt; Suzana C Schacher; Veronica V H Antunes; Bianca P Mentz; Fabiane L Oliveira; Celia Mariana B de Souza; Fernando C Schacher
Journal:  Clinics (Sao Paulo)       Date:  2014-08       Impact factor: 2.365

6.  Between-Subject Variation of the Within-Subject Biological Variation.

Authors:  Xavier Fuentes-Arderiu
Journal:  EJIFCC       Date:  2013-02-21

7.  Haemoglobin variability and all-cause mortality in haemodialysis patients: A systematic review and meta-analysis.

Authors:  Lingfei Zhao; Chenxia Hu; Jun Cheng; Ping Zhang; Hua Jiang; Jianghua Chen
Journal:  Nephrology (Carlton)       Date:  2019-02-28       Impact factor: 2.506

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.